A gene, pcbC, encoding the isopenicillin N synthase of Streptomyces griseus NRRL 3851, has been cloned in a 6.4-kb BgllI DNA fragment and located in an internal 1.55-kb PvuII segment by hybridization with the Penicilium chrysogenum pcbC gene. Hybridization studies revealed the presence of homologous sequences in the DNAs of several Streptomyces strains and Nocardia lactamdurans. The S. griseus pcbC gene was not expressed in Streptomyces lividans but was expressed in Streptomyces clavuligerus and complemented a mutation, nce2, that impaired isopenicillin N synthase and cephamycin biosynthesis. The pcbC gene contained an open reading frame of 990 nucleotides that encodes a protein of 329 amino acids with a deduced Mr of 37,371. The isopenicillin N synthase formed after expression of the pcbC gene in the S. clavuligerus nce2 mutant strain was found to have an Mr of 38,000 by gel filtration. A protein of about 38 kDa was observed in sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels of extracts of a transformant of the nce2 mutant strain; this protein was absent from the untransformed mutant strain. The G+C content of the pcbC gene was 63.6%, and the strongly biased codon usage was typical of that of Streptomyces strains. A transcription initiation site was found 44 nucleotides upstream of the ATG translation initiation triplet. A transcript of 1.1 kb was observed in the donor S. griseus strain and also in the S. clavuligerus nce2 mutant strain transformed with the pcbC gene, suggesting that it is transcribed as a monocistronic mRNA.
P-Lactam antibiotics are microbial metabolites that in-
clude the classical penicillins and cephalosporins and the more recently discovered cephamycins, nocardicins, carbapenems, clavams, and monobactams. The biosynthetic pathways of penicillins and cephalosporins are rather well understood, since most of the enzymes involved have been characterized (24) , whereas less attention has been paid to the biosynthesis of cephamycins and the newer P-lactams. Penicillins, cephalosporins, and cephamycins have in common the initial steps forming the tripeptide B(L-a-aminoadipyl)-L-cysteinyl-D-valine (ACV), mediated by the enzyme ACV synthetase, and cyclizing ACV to isopenicillin N, mediated by isopenicillin N synthase (IPNS). The latter enzyme is encoded by the gene pcbC (23) . After isopenicillin N the pathway diverges in penicillin G producers (1) and in cephalosporin and cephamycin producers (23, 26) .
A gene (pcbC) encoding IPNS has been cloned from Penicillium chrysogenum (2, 4) , Cephalosporium acremonium (Acremonium chrysogenum) (32) , Aspergillus nidulans (28) , and the cephamycin producers Streptomyces clavuligerus (20) , Streptomyces lipmanii (38) , and Streptomycesjumonjinensis (35) . Cloning and characterization ofpcbC genes from eucaryotic and procaryotic P-lactam producers are of great interest as a means of understanding the divergent evolution of similar genes. In addition, knowledge of the conserved nucleotide sequences in pcbC genes from different microorganisms will be helpful in identifying amino acids associated with cofactor and substrate binding at the active center of IPNSs.
The production by Streptomyces griseus NRRL 3851 of tamdurans were grown routinely in YEME medium or YEME medium supplemented with 1% glycerol to obtain cell mass for DNA preparation (14) . To determine the production of cephamycin C, we grew S. clavuligerus, S.
lividans, and the transformant strains in GSPG medium (30) , which supports good cephamycin production. Cultures of S. griseus for the production of cephamycins A and B were grown in medium C (37) . Cephamycin and clavulanic acid concentrations were determined by bioassay or high-pressure liquid chromatography as described previously (30) . IPNS assays. In experiments to determine IPNS activity in S. clavuligerus, in the nce2 mutant, and in transformed clones, an inoculum of each strain was grown for 48 h in a medium containing 1% malt extract, 1% Bacto-Peptone, 2% glycerol, and 1,000 ml of distilled water (pH 7.0); 10 ml was used to inoculate 100 ml of GSPG medium in 500-ml baffled flasks. Cells grown for 52 h were centrifuged and disrupted by sonication; IPNS was assayed as described previously (5, 16) .
Genomic and plasmid DNA preparations. Plasmids from Streptomyces strains were obtained by the alkaline lysis method (14) . Total DNA was obtained with the Kirby lytic mixture (14) . Fragments of S. griseus genomic DNA were separated by ultracentrifugation (SW41 rotor, L8-70 Ti Beckman ultracentrifuge) in a sucrose gradient (10 to 40%). Plasmid DNA fragments were isolated from low-meltingtemperature agarose by the procedure of Langridge et al. (19) . Escherichia coli plasmid DNA minipreparations were obtained by the procedure of Holmes and Quigley (12) .
DNA labeling and Southern hybridization. Labeling of DNA was done by nick translation with [a-32P]dCTP and the Klenow fragment of DNA polymerase (22) . DNA fragments were blotted as described by Southern (36) GARCfA-DOMfNGUEZ ET AL. were obtained. Plasmids were isolated from 96 clones, blotted to nitrocellulose filters, and hybridized with probe B. Three of the plasmids that gave a very strong hybridization signal were purified and mapped with restriction enzymes; the three contained identical 6.4-kb BgIIH DNA inserts, and one of them was designated pULMG2. The 6.4-kb fragment was subcloned into pIJ2921 (modified pUC18 with two BgIII sites in the polylinker), creating pULNFl. From this plasmid the insert could be rescued with BgIII cohesive ends.
Restriction endonuclease analysis of the 6.4-kb insert and hybridization with probe B indicated that the hybridizing region mapped in a 0.42-kb BglI fragment and in a 1.1-kb PvuII fragment internal to a larger 1.55-kb PvuII DNA fragment (Fig. 2) .
Orientation of the pcbC gene. To determine whether the whole gene was present in the 1.55-kb PvuII fragment and to establish the orientation of the gene, we carried out additional Southern hybridizations of the restriction fragments derived from the original 6.4-kb insert by using probe A (750 bp), which carried the 5' and central regions of the P. chrysogenum pcbC gene ( Expression in the S. clavuligerus nce2 mutant and complementation of the deficiency in cephamycin biosynthesis. Mutants of S. clavuligerus blocked in different steps of cephamycin biosynthesis were obtained previously (30) . Since S. clavuligerus is difficult to transform (particularly with large DNA fragments) and since there are few available vectors (10), the 6.4-kb BglII fragment of S. griseus was subcloned into the positive selection plasmid pIJ699 (18) , giving rise to plasmid pULMG13 (Fig. 3) . This plasmid was introduced into and amplified in S. lividans and used to transform the S. clavuligerus nce2 mutant for complementation studies. Figure 4 shows the production of cephamycin C and the unrelated ,-lactamase inhibitor clavulanic acid by the S. clavuligerus nce2 mutant transformed with pULMG13. Control cultures were grown in parallel with the wild-type strain S. clavuligerus NRRL 3585, the nce2 mutant, and the wild-type strain transformed with pIJ702; control cultures of S. clavuligerus transformed with pIJ699 without inserts do not accept the long E. coli DNA stuffer present in pIJ699, and the plasmid is lost.
The addition of thiostrepton (2 jig/ml) (a positive selection agent required to stabilize the plasmids) to the cultures produced a delay in the growth phase and, therefore, reduced by 20 to 30% the levels of cephamycin and clavulanic acid produced by the wild type. Clones of the S. clavuligerus nce2 mutant transformed with pULMG13 regained the ability to produce cephamycin C, although the level of cephamycin produced was about one-third that produced in the wild type grown with thiostrepton ( Fig. 4B ) (see Discussion).
The production of clavulanic acid in the nce2 mutant was not affected by the introduction of the 6.4-kb DNA fragment carrying the pcbC gene. The production of clavulanic acid was significantly higher in both strains [nce2 and nce2(pULMG13)] than in the wild type, confirming previous results (30 38, 000) that was present in the wild type and lacking in the nce2 mutant was formed in the S. clavuligerus nce2(pULMG13) transformant (Fig. 5) . The Mr of this protein agrees with the Mr of IPNS established by gel filtration (see above) and with the Mr s established for other cyclases (see Discussion).
Nucleotide sequence of the pcbC gene. With the strategy indicated in Fig. 2 , the nucleotide sequence of a 1.36-kb PvuII-BglI DNA fragment was established (Fig. 6) . This region contained an open reading frame of 990 nucleotides encoding a protein of 329 amino acids with a deduced molecular weight of 37,371 and a pl of 5.67. Two in-frame ATG triplets were present in the region of the expected initiation of the open reading frame. Computer analysis of the nucleotide sequence revealed the presence of a putative Shine-Dalgarno sequence, GGAGG, 6 to 11 nucleotides upstream of the first ATG initiation triplet. This location agrees with the location of the Shine-Dalgarno sequences for most Streptomyces genes involved in antibiotic biosynthesis (13, 25) . The Mr of the protein encoded by the open reading frame defined by this initiation triplet correlated closely with the Mr (38,000) determined by gel filtration and SDS-polyacrylamide gel electrophoresis.
A 12-bp inverted repeat sequence 52 nucleotides downstream from the TGA termination codon may form two alternative stem and loop structures (Fig. 6 ) with free energy charges of -22.8 and -20.2 kcal/mol (ca. -95.3 and -84.5 kJ/mol, respectively). This structure may play a role in transcription termination.
The G+C content of the open reading frame was 63.6%. The codon usage was typical of that of Streptomyces strains, and the G+C contents in the first, second, and third codon positions were 58, 38, and 94%, respectively; i.e., almost all triplets in the gene contained a G or a C in the third position in the codon, resulting in a strongly biased codon utilization (13) .
The nucleotide sequence of the S. griseus pcbC gene and the deduced amino acid sequence of the gene product were very similar to those of other fungal and Streptomyces pcbC genes and their gene products (Fig. 7) (Fig. 8) . The S. clavuligerus nce2(pULMG13) transformant also formed a transcript of the same size, although with a lower hybridization intensity than in S. griseus. This result correlates with the low level of cephamycin formation described above. No significant hybridization was observed with the ItNA of S. clavuligerus or the untransformed nce2 mutant because of the use of an S. griseus probe under stringent conditions. A minor band of about 1.5 kb hybridized with the same probe in the total RNA from S. griseus or S. clavuligerus transformed with pULMG13, suggesting the formation of two transcripts, probably from different transcription start sites (see below and Discussion).
Transcription initiation. To confirm the presence of a specific promoter for the pcbC gene and to characterize the initiation of transcription, we carried out Si nuclease mapping protection studies by using a 401-bp PvuII fragment that carries the ATG initiation triplet at position 246 (Fig. 9) 
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t m rg f ate t gkp ed f f deas t st edt tI sav t CTGATCCACTACCCGTACCT GGAGGACTACCCGCCGGTCAAGACAGGCCCGGACGGCACGAAGCT GAGCTTCGAGGACCACCTGGACGT GTCGATGATCA production, failed to synthesize any detectable trace of cephamycin. Furthermore, pcbC cloned from S. griseus (in the 6.4-kb S. griseus DNA fragment that carries the promoter and the structural gene) was not expressed to a detectable extent in S. lividans, whereas it was expressed and restored cephamycin C biosynthesis in the S. clavuligerus nce2 mutant (Fig. 4) , which is blocked in the IPNS step (30) . The fact that the pcbC gene was expressed in S.
clavuligerus nce2 transformants but not in S. lividans with the same construction (pULMG13) suggests that expression requires a positively acting regulatory protein which occurs in S. clavuligerus (a cephamycin producer) but not in S.
lividans. Similar results were observed by Cox et al. (6) (Fig. 5) . The size of the enzyme of S. griseus is similar to those of the purified IPNSs of S. clavuligerus (33 kDa) (16) (20, 35, 38) .
The alignment of the amino acid sequence of the IPNS of S. griseus with those of six other known IPNSs revealed extensive sequence similarities (shaded areas in Fig. 7) (23, 24) . As a result, it is not possible to define precisely those regions involved in substrate binding and/or catalytic activity. Two cysteines (amino acid residues at positions 104 and 251) that have been proved to be important for the activity of the IPNS of C. acremonium (33) are also conserved in the IPNS of S. griseus and in all known IPNSs (arrowheads in Fig. 7 ). Both of them are located in a stretch of conserved amino acids and may be important in forming a thiol bridge via an iron atom (33) , a cofactor of fungal and bacterial IPNSs (5, 16, 29) . The S. griseus IPNS also contains two nonconserved cysteine residues at positions 37 and 142 that exist in some procaryotic IPNSs but not in the fungal enzymes.
S. griseus IPNS contains a tyrosine at position 197 which is conserved in all IPNSs, including that of P. chrysogenum AS-P-78 but with the exception of that of a strain (23-X-80-269-37-2) producing large amounts of penicillin (2, 4) . This change from tyrosine to isoleucine may have been introduced during the strain improvement program, but the role of this mutation in IPNS activity is unclear.
